November 9, 2022

Intent to Reissue MIRA Funding Opportunity Announcement for Early Stage Investigators (R35)

I’m pleased to announce that the funding opportunity announcement (FOA) for the Maximizing Investigators’ Research Award (MIRA) for early stage investigators (ESIs) will be reissued in the spring of 2023. MIRA provides support for a research program in an ESI’s laboratory that falls within the NIGMS mission. For details, see NOT-GM-23-017

The reissued FOA will essentially be the same as the previous one, with a couple of minor changes:

  1. There will be two application receipt dates per year—February and October.
  2. Applications must include a plan for enhancing diverse perspectives, which is a new requirement for this FOA.

Important Note: MIRA FOA PAR-22-180 funding is limited to eligible NIGMS-funded investigators and new investigators. Current ESIs should not apply to PAR-22-180. ESI MIRA applications will be reviewed separately from MIRA applications submitted to PAR-22-180.


About the Author

Sailaja Koduri.

Sailaja Koduri

A biochemist with previous biotech industry experience, Sailaja administers research grants in the areas of receptors, drug targets, and signal transduction; training grants in pharmacological sciences; and serves as a program contact for the Maximizing Investigators' Research Award for early stage investigators.